Clinical trial
Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management
NCT04567225 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management
- Lead sponsor
- The Cleveland Clinic
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- October 1, 2020
- Completion date
- August 27, 2021
- Enrollment
- 39 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic ketoacidosis, type 1 diabetes, type 2 diabetes